WA
MXCT icon

Waverly Advisors’s MaxCyte MXCT Stock Holding History

Waverly Advisors’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.4K Buy
54,014
+1,994
+4% +$1.99K ﹤0.01% 1698
2026
Q1 		$36.5K Buy
52,020
+1,753
+3% +$1.64K ﹤0.01% 1573
2025
Q4 		$77.9K Buy
50,267
+1
+0% +$2 ﹤0.01% 1439
2025
Q3 		$79.4K Buy
+50,266
New +$87.4K ﹤0.01% 1261

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Waverly Advisors's MXCT Position: Q2 2026 in Review

Waverly Advisors increased its MaxCyte (MXCT) stake by 3.8% in Q2 2026, buying an estimated $1.99K and bringing the position to 54,014 shares worth $66.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1698.

Waverly Advisors first reported a position in MXCT in Q3 2025 and has held it in 4 quarters since. The position peaked at $79.4K in Q3 2025. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Waverly Advisors held 54,014 shares of MaxCyte worth $66.4K as of Q2 2026.
  • Waverly Advisors bought 1,994 MaxCyte shares in Q2 2026, an estimated $1.99K.
  • MaxCyte made up ﹤0.01% of Waverly Advisors's portfolio in Q2 2026, its #1698 holding.
  • Waverly Advisors first reported a position in MaxCyte in Q3 2025 and has held it in 4 quarters since.
  • Waverly Advisors's MaxCyte position peaked at $79.4K in Q3 2025.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Waverly Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.